# Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/advancing-basal-insulin-replacement-in-type-2-diabetes-inadequately-controlled/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Julio Rosenstock,Vivian Fonseca,Jorge Luiz Gross,Robert E. Ratner,Bo Åhrén,Francis C. C. Chow,Fred Yang,Diane Miller,Susan Johnson,Murray Stewart,Lawrence A. Leiter |
| Citations | 206 |
| DOI | 10.2337/dc14-0001 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2137562839 |
| PMID | 24898300 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Fred Yang](https://scholariq.org/researchers/fred-yang/)
- [Murray Stewart](https://scholariq.org/researchers/murray-stewart/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

## Paper topics

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.